News Overview

2014-07-10
Probiodrug Presents Development Overview of PQ912, Probiodrug’s QC-Inhibitor for Alzheimer’s Disease

HALLE/SAALE, Germany, July X, 2014 – Probiodrug AG (Probiodrug) announced that Prof. Hans-Ulrich Demuth, co-founder and consultant to the company, will give a talk detailing clinical development of PQ912 at the upcoming Alzheimer’s Association International Conference in Copenhagen, Denmark. The pre … more

2014-06-19
Probiodrug to Present at Annual BIO International Convention

HALLE/SAALE, Germany, June 19, 2014 – Probiodrug AG (Probiodrug), today announced that Dr. Hendrik Liebers, Probiodrug’s chief financial officer, will present a corporate update at the annual BIO International Convention, being held from the 23rd to the 26th of June 2014. Dr. Lieber’s presentati … more

2014-06-02
Probiodrug to Present at 2014 Asia Biotech Invest Conference

HALLE/SAALE, Germany, June 2, 2014 – Probiodrug AG (Probiodrug), today announced that the Company will participate in the second annual Asia Biotech Invest conference, to be held at the Sheraton Hotel & Towers in Hong Kong. The presentation, given by Dr Konrad Glund, Probiodrug’s chief executive … more

2014-05-19
Probiodrug to Present at Annual BioEquity Europe Conference

HALLE/SAALE, Germany, May 19, 2014 – Probiodrug AG (Probiodrug), today announced that Dr. Hendrik Liebers, chief financial officer of Probiodrug, will be presenting a corporate update at the annual BioEquity Europe conference, being held 21–22 May 2014. Dr. Liebers’ presentation will take place at 4 … more

2014-03-26
Probiodrug to Present at BioCapital Europe 2014

HALLE/SAALE, Germany, March 26th, 2014 – Probiodrug AG (Probiodrug), today announced that Dr. Hendrik Liebers, the Company’s chief financial officer, will provide an update of corporate, scientific and clinical accomplishments at BioCapital Europe 2014 in Amsterdam. Dr Liebers` presentation will tak … more